Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

PPARalpha and dyslipidemia.

Caroline Duval1, Michael Müller, Sander Kersten

  • 1Nutrition, Metabolism and Genomics Group and Nutrigenomics Consortium, Wageningen University, P.O. Box 8129, 6700 EV Wageningen, Netherlands.

Biochimica Et Biophysica Acta
|July 3, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Paneth cell SIRT1 deficiency increases intestinal stress resistance by modulating the gut microbiota.

EMBO reports·2026
Same author

NAPRT-mediated deamidated NAD biosynthesis enhances colon tissue resiliency and suppresses tumorigenesis.

Nature communications·2026
Same author

[Motivations and limitations of French pathology residents in choosing their future location and mode of professional practice].

Annales de pathologie·2025
Same author

CYP eicosanoid pathway mediates colon cancer-promoting effects of dietary linoleic acid.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2023
Same author

Role of linoleic acid-derived oxylipins in cancer.

Cancer metastasis reviews·2020
Same author

Expression of <i>Cyp2c</i>/<i>Cyp2j</i> subfamily members and oxylipin levels during LPS-induced inflammation and resolution in mice.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2019
Same journal

Cumulative Contents.

Biochimica et biophysica acta·2020
Same journal

Molecular Basis of Disease Cumulative Contents.

Biochimica et biophysica acta·2020
Same journal

General Subjects Cumulative Contents.

Biochimica et biophysica acta·2020
Same journal

Erratum to 'on the role of exchangeable hydrogen bonds for the kinetics of P680<sup>+·</sup> Q<sub>A</sub> <sup>-·</sup> formation and P680<sup>+·</sup> Pheo<sup>-·</sup> recombination in photosystem II' [Biochim. Biophys. Acta 1276 (1996) 35-44].

Biochimica et biophysica acta·2019
Same journal

Oligomeric state of the light-harvesting complexes B800-850 and B875 from purple bacterium Rubrivivax gelatinosus in detergent solution.

Biochimica et biophysica acta·2019
Same journal

Regulation of pigment content and enzyme activity in the cyanobacterium Nostoc sp. Mac grown in continuous light, a light-dark photoperiod, or darkness.

Biochimica et biophysica acta·2019
See all related articles

Fibrates, activating peroxisome proliferator-activated receptor alpha (PPARalpha), reduce triglyceride levels and increase HDL cholesterol by regulating genes involved in lipoprotein metabolism.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Genetics

Background:

  • Dyslipidemia involves abnormal plasma lipoprotein levels.
  • Fibrates are key drugs for treating dyslipidemia.
  • Fibrates act as agonists for peroxisome proliferator-activated receptor alpha (PPARalpha).

Purpose of the Study:

  • To present a fresh perspective on PPARalpha's molecular mechanisms in modulating plasma lipoproteins.
  • To integrate novel insights into lipoprotein metabolism and PPARalpha-dependent gene regulation.

Main Methods:

  • Investigating PPARalpha as a ligand-activated transcription factor.
  • Analyzing PPARalpha's binding to target gene promoters.
  • Examining PPARalpha's role in regulating genes involved in metabolic processes.

Related Experiment Videos

Main Results:

  • PPARalpha activation reduces plasma triglyceride levels by decreasing very-low-density lipoprotein (VLDL) secretion and enhancing lipolysis.
  • PPARalpha increases high-density lipoprotein (HDL) levels in humans via enhanced apolipoprotein A1 (APOA1) and A2 (APOA2) production.
  • PPARalpha modulates lipoprotein metabolism through direct up-regulation of specific target genes.

Conclusions:

  • PPARalpha plays a crucial role in regulating plasma lipoprotein levels.
  • Understanding PPARalpha's gene regulatory functions provides insight into treating dyslipidemia.
  • Novel insights into PPARalpha mechanisms offer a refined perspective on its therapeutic effects.